Low-dose naltrexone for ME/CFS: finding the right dose
Treatments studied
Part of Bones, joints & muscles, Brain & nervous system clinical trials.
This study tests a low dose of naltrexone, a medicine that may help reduce fatigue and other symptoms of ME/CFS (myalgic encephalomyelitis/chronic fatigue syndrome). The goal is to find the best dose that works for people living in Alabama.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old.
- You live in Alabama.
- You have been diagnosed with ME/CFS using the ME-ICC criteria.
- You do not have liver or kidney problems, or abnormal blood counts.
- You do not have an active infection, an autoimmune disorder, or diabetes with an A1C over 9%.
- You are not taking opioid pain medicines and are not pregnant or planning to become pregnant.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies whether a low dose of naltrexone can reduce long-lasting nerve-related pain in adults living with HIV. It may help if your pain has been ongoing and you have stable HIV control.
This trial tests if a low dose of the drug naltrexone can help reduce fatigue in men with prostate cancer who are currently receiving hormone therapy (ADT). It may offer a new way to manage tiredness during treatment.
This trial tests whether a low dose of naltrexone, a medication that may help calm overactive immune and pain signals, can reduce pain and improve daily life in people with complex regional pain syndrome (CRPS), a chronic condition that often causes severe pain and swelling.
This Phase 2 study tests whether low-dose naltrexone can reduce pain from vulvodynia. It also looks at how well it works across different vulvodynia types, comparing to what participants are already doing for symptoms.
This trial tests whether low-dose naltrexone can reduce symptoms of complex regional pain syndrome (CRPS), a long-lasting pain condition in an arm or leg. It may help by targeting pain signaling, but you must meet specific CRPS diagnosis and medication rules to join.
This trial tests a new treatment for ME/CFS (chronic fatigue syndrome) that includes symptoms like dizziness when standing. It uses a smartphone app to track your progress and aims to see if the treatment can improve your daily life.
Hear when a new Myalgic Encephalomyelitis/Chronic Fatigue Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.